# Jean‐Yves Blay

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jean-yves-blay/

## Facts

| Field | Value |
| --- | --- |
| Citations | 96,123 |
| Field | Sarcoma Diagnosis and Treatment |
| h-index | 158 |
| i10-index | 859 |
| Last Known Institution | Université Claude Bernard Lyon 1 |
| OpenAlex ID | https://openalex.org/A5042202815 |
| ORCID iD | https://orcid.org/0000-0001-7190-120X |
| Works | 2,354 |

## Researcher papers

Showing 12 of 17.

- [Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up](https://scholariq.org/papers/soft-tissue-and-visceral-sarcomas-esmo-euracan-clinical-practice-guidelines-for/)
- [Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆](https://scholariq.org/papers/soft-tissue-and-visceral-sarcomas-esmo-euracan-genturis-clinical-practice/)
- [Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up](https://scholariq.org/papers/gastrointestinal-stromal-tumours-esmo-euracan-clinical-practice-guidelines-for/)
- [Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up](https://scholariq.org/papers/bone-sarcomas-esmo-paedcan-euracan-clinical-practice-guidelines-for-diagnosis/)
- [Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study](https://scholariq.org/papers/safety-and-efficacy-of-denosumab-for-adults-and-skeletally-mature-adolescents/)
- [Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up](https://scholariq.org/papers/gastrointestinal-stromal-tumours-esmo-euracan-genturis-clinical-practice/)
- [Deep learning-based classification of mesothelioma improves prediction of patient outcome](https://scholariq.org/papers/deep-learning-based-classification-of-mesothelioma-improves-prediction-of/)
- [Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules](https://scholariq.org/papers/efficacy-and-safety-of-trabectedin-in-patients-with-advanced-or-metastatic/)
- [Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial](https://scholariq.org/papers/histotype-tailored-neoadjuvant-chemotherapy-versus-standard-chemotherapy-in/)
- [Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial](https://scholariq.org/papers/preoperative-radiotherapy-plus-surgery-versus-surgery-alone-for-patients-with/)
- [Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial](https://scholariq.org/papers/afamitresgene-autoleucel-for-advanced-synovial-sarcoma-and-myxoid-round-cell/)
- [Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups](https://scholariq.org/papers/neoadjuvant-chemotherapy-in-high-risk-soft-tissue-sarcomas-final-results-of-a/)

## Researcher topics

- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)
- [Gastrointestinal Tumor Research and Treatment](https://scholariq.org/topics/gastrointestinal-tumor-research-and-treatment/)
- [Vascular Tumors and Angiosarcomas](https://scholariq.org/topics/vascular-tumors-and-angiosarcomas-2/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)

## Researcher university

- [Lyon 1 Université](https://scholariq.org/institutions/lyon-1-universite/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.